Qyuns Therapeutics Co., Ltd. 江蘇荃信生物醫藥股份有限公司

Pay for financial year ended 2023-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Supervisors

1 Ding, Chao (1987) 丁超 Supervisor
2 Wang, Yujiao (1981) 王玉姣 Supervisor 598 160 43 4,155 4,956
3 Ye, Xiang (1982) 葉翔 Sup Ch
Total 0 598 160 43 4,155 4,956

Directors

4 Lin, Weidong (1982) 林偉棟 ED 1,297 400 68 6,963 8,728
5 Qiu, Jiwan 裘霽宛 Ch, CEO, Fdr 1,858 720 43 55,490 58,111
6 Wu, Yiliang 吳亦亮 ED 1,073 300 43 4,843 6,259
7 Wu, Zhiqiang (1981) 吳志強 NED
8 Xue, Mingyu 薛明宇 NED
9 Yu, Xi (1973) 余熹 NED
Total 0 4,228 1,420 154 67,296 73,098
Grand total 0 4,826 1,580 197 71,451 78,054

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 555 4,221 1,420 161 44,569 50,926 Report
2023-12-31 0 4,228 1,420 154 67,296 73,098 Report
Total 555 8,449 2,840 315 111,865 124,024

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top